Search

everythinglearnresearchcommunity

for

Search:↓

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

The new drug delivery system improves exemestane's absorption and effectiveness.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Some patients' hair grew back black and white after chemotherapy.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.